News Headlines Article

Amgen posts higher quarterly profit, sales
Los Angeles Business Journal

Biotech company Amgen Inc. reported a better-than-expected jump in third-quarter profits amid higher sales and prices across most of its drugs. Thousand Oaks-based Amgen(Nasdaq: AMGN) said it earned $1.86 billion, or $2.44 per share, up from $1.24 billion, or $1.61 per share, a year earlier. Earnings excluding one-time charges was $2.72 per share, widely beating the $2.37 per share expected by analysts polled by FactSet.